A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia - Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Description:

This was a multicenter, randomized double-blinded clinical trial designed to test the lipid-altering effects of two insulin-sensitizing drugs (pioglitazone vs. rosiglitazone) in patients with type 2 diabetes with dyslipidemia.